WIJNGAARD PETER purchased 199.9% of their position (3K shares) of HEPION PHARMACEUTICALS, INC. on the open market
Open‑market purchase worth $16.8K — a major conviction buy. The strongest form of insider conviction signal.
P · 4 purchases
Filed: 9/20/2023ACC: 0001104659-23-102209
Director
Since Jun 2020
+3K
Net shares
Net buyer
$16.8K
Total acquired
4
Open market trades
4B · 0S
4
Total transactions
3K acquired
Non-Derivative Transactions4
Common Stock
Direct
Shares
+1K
Price / share
$5.82
Trade value
$5.82K
% of position
66.6%
9/15/2023
1.50K→2.50K
Common Stock
Direct
Shares
+139.00
Price / share
$5.45
Trade value
$757.55
% of position
5.6%
9/15/2023
2.50K→2.64K
Common Stock
Direct
Shares
+861.00
Price / share
$5.37
Trade value
$4.62K
% of position
32.6%
9/15/2023
2.64K→3.50K
Common Stock
Direct
Shares
+1K
Price / share
$5.64
Trade value
$5.64K
% of position
28.6%
9/19/2023
3.50K→4.50K
Total
Net shares
+3K
Net value
$16.84K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/15/2023 | P · Purchase | +1K | $5.82 | $5.82K | 66.6% | 1.50K | 2.50K |
| Common Stock Direct | 9/15/2023 | P · Purchase | +139.00 | $5.45 | $757.55 | 5.6% | 2.50K | 2.64K |
| Common Stock Direct | 9/15/2023 | P · Purchase | +861.00 | $5.37 | $4.62K | 32.6% | 2.64K | 3.50K |
| Common Stock Direct | 9/19/2023 | P · Purchase | +1K | $5.64 | $5.64K | 28.6% | 3.50K | 4.50K |
| Total | +3K | $16.84K | ||||||
Derivative Transactions0
No derivative transactions reported